Skip Navigation

2007/034 NICE issues guidance on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma

NICE has issued guidance today (27 June 2007) on the use of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma, a type of cancerous brain tumour.

Search NICE guidance


Advanced guidance search